Chemical & Pharmaceutical Research

Chemical & Pharmaceutical Research

Open Access
ISSN: 2689-1050
Research Article

The Effects of Nanotechnology and Theranostic on Neurodegenerative Diseases

Authors: Marelis Molina Otero, Kevin B Sneed, Yashwant V Pathak.

DOI: 10.33425/2689-1050.1058


Abstract

Nanotechnology and nanomedicine have significantly advanced diagnostics and treatments for life-threatening and disabling diseases. Nanoparticle properties and characteristics are the most impactful force in medicine. Their size, shape, charge, surface area, solubility, and many other properties are substantial in diagnosing and treating. Their size and surface area are inversely proportional to each other. In other words, the smaller the size, the higher the surface area. Thus, their dose is less, better penetration, solubility, bioavailability, point-specific location, fewer side effects, and less toxicity.

Nanoparticles have opened new potential for diagnosis and treatment of neurodegenerative disorders. Neurodegenerative disorders affect the central nervous system (CNS) and disrupt communication between neurons vital for motor, sensory, and cognitive processes. The usage of Nanotheranostic has shown advances in the discovery of potential methods that can reduce inflammation, aggregates, and reactive oxygen species (ROS). Lastly, it is expected that there will be more usage of nanoparticles to detect and treat neurodegenerative disorders like Alzheimer’s and Parkinson’s.

View / Download PDF
Citation: Marelis Molina Otero,  Kevin B Sneed,  Yashwant V Pathak. The Effects of Nanotechnology and Theranostic on Neurodegenerative Diseases. 2024; 6(1). DOI: 10.33425/2689-1050.1058
Editor-in-Chief
Yousra A. R. Nomier
Yousra A. R. Nomier
College of Pharmacy | Jazan University

View full editorial board →
Journal Metrics
Impact Factor 2.08*
Acceptance Rate 78%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days